Based on our findings, we propose that measuring serum Ig levels, T (including CD4+ and CD8+ subsets), B and NK lymphocytes at PreTx, 1M, 6M and 12M provides a comprehensive assessment of immune recovery and identifies late infections risks. This evidence concerns the gene CD8A and infection.